Clinical implications of the coexpression of SRC1 and NANOG in HER-2-overexpressing breast cancers

Clinical implications of the coexpression of SRC1 and NANOG in HER-2-overexpressing breast cancers

Chengyan Jin,1 Xingyi Zhang,1 Mei Sun,2 Yifan Zhang,1 Guangxin Zhang,1 Bin Wang1 1Department of Thoracic Surgery, 2Department of Pathology, The Second Affiliated Hospital of Jilin University, Changchun, People’s Republic of China Objective: Given the lack of clarity on the expression sta...

Full description

Bibliographic Details
Main Authors: Jin CY, Zhang XY, Sun M, Zhang YF, Zhang GX, Wang B
Format: Article
Language:English
Published: Dove Medical Press 2016-09-01
Series:OncoTargets and Therapy
Subjects:
breast cancer
prognosis
molecular classification
SRC1
NANOG
Online Access:https://www.dovepress.com/clinical-implications-of-the-coexpression-of-src1-and-nanog-in-her-2-o-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/clinical-implications-of-the-coexpression-of-src1-and-nanog-in-her-2-o-peer-reviewed-article-OTT

Similar Items